VThunter
a database for single-cell screening of virus target cells in animal kingdom
Civet

Taxonomy: Cellular organisms; Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata; Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Mammalia; Theria; Eutheria; Boreoeutheria; Laurasiatheria; Carnivora; Feliformia,

Latin Name: Paguma larvata

Tested tissues: Frontal, Kidney, Liver, Lung, Spleen,

Data set information
Project Date Technology Tissue Condition Cell PMID/DOI
Vthunter_0007 2021.04 10X Genomics Frontal Normal 6593 Link
Vthunter_0008 2021.04 10X Genomics Kidney Normal 1930 Link
Vthunter_0009 2021.04 10X Genomics Liver Normal 34029 Link
Vthunter_0010 2021.04 10X Genomics Lung Normal 12863 Link
Vthunter_0011 2021.04 10X Genomics Spleen Normal 9682 Link
Virus Virus Name GeneTop 5 cell types expressing viral receptor ordered by expression proportion
Rabies lyssavirus
Frontal-Excitatory neurons : 94.25% ;
Frontal-Inhibitory neurons : 93.08% ;
Frontal-Astrocytes : 75.90% ;
Frontal-Oligodendrocyte progenitor cells : 74.87% ;
Frontal-Oligodendrocytes : 64.08% ;
Frontal-Excitatory neurons : 58.18% ;
Encephalomyocarditis virus
Spleen-Macrophages : 93.90% ;
Spleen-T follicular helper cells : 93.54% ;
Spleen-T cells : 83.65% ;
Spleen-Dendritic cells : 79.06% ;
Spleen-B cells : 78.26% ;
Severe acute respiratory syndrome coronavirus 2
Spleen-T cells : 93.64% ;
Lung-ATI : 77.51% ;
Lung-ATII : 67.39% ;
Spleen-Endothelial cells : 67.14% ;
Lung-Endothelial cells : 57.66% ;
Foot-and-mouth disease virus
Spleen-Natural killer cells : 93.46% ;
Liver-Cholangiocytes : 86.88% ;
Lung-ATI : 80.40% ;
Lung-Ciliated cells : 77.73% ;
Kidney-Distal convoluted tubule cells : 72.17% ;
Lung-ATI : 91.98% ;
Lung-ATII : 91.14% ;
Lung-Ciliated cells : 71.82% ;
Lung-Fibroblasts : 64.20% ;
Lung-Epithelial cells : 62.04% ;
Lung-ATI : 73.85% ;
Lung-Epithelial cells : 66.42% ;
Spleen-B cells : 62.66% ;
Spleen-Fibroblasts : 59.49% ;
Lung-ATII : 55.82% ;
Lung-ATI : 64.28% ;
Lung-Epithelial cells : 48.18% ;
Spleen-Macrophages : 42.48% ;
Lung-Ciliated cells : 40.45% ;
Spleen-B cells : 40.28% ;
Human alphaherpesvirus 1
Spleen-Natural killer cells : 93.46% ;
Liver-Cholangiocytes : 86.88% ;
Lung-ATI : 80.40% ;
Lung-Ciliated cells : 77.73% ;
Kidney-Distal convoluted tubule cells : 72.17% ;
Lung-ATI : 91.98% ;
Lung-ATII : 91.14% ;
Lung-Ciliated cells : 71.82% ;
Lung-Fibroblasts : 64.20% ;
Lung-Epithelial cells : 62.04% ;
Lung-ATI : 64.28% ;
Lung-Epithelial cells : 48.18% ;
Spleen-Macrophages : 42.48% ;
Lung-Ciliated cells : 40.45% ;
Spleen-B cells : 40.28% ;
Coxsackievirus B1
Lung-ATI : 91.98% ;
Lung-ATII : 91.14% ;
Lung-Ciliated cells : 71.82% ;
Lung-Fibroblasts : 64.20% ;
Lung-Epithelial cells : 62.04% ;
Lung-ATI : 78.41% ;
Frontal-Excitatory neurons : 63.97% ;
Lung-Ciliated cells : 55.91% ;
Lung-ATII : 43.74% ;
Liver-Cholangiocytes : 43.73% ;
Lung-ATI : 64.28% ;
Lung-Epithelial cells : 48.18% ;
Spleen-Macrophages : 42.48% ;
Lung-Ciliated cells : 40.45% ;
Spleen-B cells : 40.28% ;
Coxsackievirus A9
Lung-ATI : 91.98% ;
Lung-ATII : 91.14% ;
Lung-Ciliated cells : 71.82% ;
Lung-Fibroblasts : 64.20% ;
Lung-Epithelial cells : 62.04% ;
Lung-ATI : 64.28% ;
Lung-Epithelial cells : 48.18% ;
Spleen-Macrophages : 42.48% ;
Lung-Ciliated cells : 40.45% ;
Spleen-B cells : 40.28% ;
Equid alphaherpesvirus 1
Spleen-Regulatory T cells : 88.97% ;
Spleen-B cells : 74.04% ;
Spleen-Naive T cells : 67.97% ;
Spleen-Endothelial cells : 48.50% ;
Spleen-Dendritic cells : 45.44% ;
Lung-ATI : 73.85% ;
Lung-Epithelial cells : 66.42% ;
Spleen-B cells : 62.66% ;
Spleen-Fibroblasts : 59.49% ;
Lung-ATII : 55.82% ;
Influenza A virus
Lung-ATI : 88.95% ;
Frontal-Excitatory neurons : 84.30% ;
Lung-ATII : 82.84% ;
Spleen-Macrophages : 80.08% ;
Lung-Ciliated cells : 79.09% ;
Lung-ATI : 78.62% ;
Spleen-Natural killer cells : 58.02% ;
Lung-Epithelial cells : 54.74% ;
Lung-Ciliated cells : 50.45% ;
Lung-Endothelial cells : 45.63% ;
Lung-ATI : 58.93% ;
Liver-Hepatocytes : 50.34% ;
Lung-ATII : 45.79% ;
Liver-Liver sinusoidal endothelial cells : 41.21% ;
Lung-Ciliated cells : 40.91% ;
Vesicular stomatitis virus
Lung-ATI : 88.95% ;
Frontal-Excitatory neurons : 84.30% ;
Lung-ATII : 82.84% ;
Spleen-Macrophages : 80.08% ;
Lung-Ciliated cells : 79.09% ;
Human gammaherpesvirus 4
Lung-ATI : 88.31% ;
Spleen-B cells : 85.04% ;
Spleen-Macrophages : 83.33% ;
Lung-Macrophages : 66.23% ;
Spleen-Natural killer cells : 64.77% ;
Lung-ATI : 73.85% ;
Lung-Epithelial cells : 66.42% ;
Spleen-B cells : 62.66% ;
Spleen-Fibroblasts : 59.49% ;
Lung-ATII : 55.82% ;
Mouse mammary tumor virus
Frontal-Endothelial cells : 85.00% ;
Lung-ATII : 46.77% ;
Lung-Epithelial cells : 36.50% ;
Canine parvovirus
Frontal-Endothelial cells : 85.00% ;
Lung-ATII : 46.77% ;
Lung-Epithelial cells : 36.50% ;
Feline panleukopenia virus
Frontal-Endothelial cells : 85.00% ;
Lung-ATII : 46.77% ;
Lung-Epithelial cells : 36.50% ;
Argentinian mammarenavirus
Frontal-Endothelial cells : 85.00% ;
Lung-ATII : 46.77% ;
Lung-Epithelial cells : 36.50% ;
Guanarito mammarenavirus
Frontal-Endothelial cells : 85.00% ;
Lung-ATII : 46.77% ;
Lung-Epithelial cells : 36.50% ;
Machupo mammarenavirus
Frontal-Endothelial cells : 85.00% ;
Lung-ATII : 46.77% ;
Lung-Epithelial cells : 36.50% ;
Hepacivirus C
Frontal-Endothelial cells : 85.00% ;
Lung-ATII : 46.77% ;
Lung-Epithelial cells : 36.50% ;
Frontal-Endothelial cells : 76.67% ;
Lung-ATI : 68.50% ;
Lung-ATII : 54.37% ;
Lung-Ciliated cells : 54.09% ;
Lung-Endothelial cells : 47.94% ;
Lung-ATI : 58.93% ;
Liver-Hepatocytes : 50.34% ;
Lung-ATII : 45.79% ;
Liver-Liver sinusoidal endothelial cells : 41.21% ;
Lung-Ciliated cells : 40.91% ;
Coxsackievirus B5
Lung-ATI : 78.41% ;
Frontal-Excitatory neurons : 63.97% ;
Lung-Ciliated cells : 55.91% ;
Lung-ATII : 43.74% ;
Liver-Cholangiocytes : 43.73% ;
Coxsackievirus B4
Lung-ATI : 78.41% ;
Frontal-Excitatory neurons : 63.97% ;
Lung-Ciliated cells : 55.91% ;
Lung-ATII : 43.74% ;
Liver-Cholangiocytes : 43.73% ;
Coxsackievirus B3
Lung-ATI : 78.41% ;
Frontal-Excitatory neurons : 63.97% ;
Lung-Ciliated cells : 55.91% ;
Lung-ATII : 43.74% ;
Liver-Cholangiocytes : 43.73% ;
Coxsackievirus B2
Lung-ATI : 78.41% ;
Frontal-Excitatory neurons : 63.97% ;
Lung-Ciliated cells : 55.91% ;
Lung-ATII : 43.74% ;
Liver-Cholangiocytes : 43.73% ;
Coxsackievirus B6
Lung-ATI : 78.41% ;
Frontal-Excitatory neurons : 63.97% ;
Lung-Ciliated cells : 55.91% ;
Lung-ATII : 43.74% ;
Liver-Cholangiocytes : 43.73% ;
Human mastadenovirus A
Lung-ATI : 78.41% ;
Frontal-Excitatory neurons : 63.97% ;
Lung-Ciliated cells : 55.91% ;
Lung-ATII : 43.74% ;
Liver-Cholangiocytes : 43.73% ;
Human mastadenovirus D
Lung-ATI : 78.41% ;
Frontal-Excitatory neurons : 63.97% ;
Lung-Ciliated cells : 55.91% ;
Lung-ATII : 43.74% ;
Liver-Cholangiocytes : 43.73% ;
Human mastadenovirus F
Lung-ATI : 78.41% ;
Frontal-Excitatory neurons : 63.97% ;
Lung-Ciliated cells : 55.91% ;
Lung-ATII : 43.74% ;
Liver-Cholangiocytes : 43.73% ;
Human mastadenovirus E
Lung-ATI : 78.41% ;
Frontal-Excitatory neurons : 63.97% ;
Lung-Ciliated cells : 55.91% ;
Lung-ATII : 43.74% ;
Liver-Cholangiocytes : 43.73% ;
Human mastadenovirus C
Lung-ATI : 78.41% ;
Frontal-Excitatory neurons : 63.97% ;
Lung-Ciliated cells : 55.91% ;
Lung-ATII : 43.74% ;
Liver-Cholangiocytes : 43.73% ;
Lung-ATI : 64.28% ;
Lung-Epithelial cells : 48.18% ;
Spleen-Macrophages : 42.48% ;
Lung-Ciliated cells : 40.45% ;
Spleen-B cells : 40.28% ;
Mammalian orthoreovirus
Lung-ATI : 73.85% ;
Lung-Epithelial cells : 66.42% ;
Spleen-B cells : 62.66% ;
Spleen-Fibroblasts : 59.49% ;
Lung-ATII : 55.82% ;
Human betaherpesvirus 5
Lung-ATI : 73.85% ;
Lung-Epithelial cells : 66.42% ;
Spleen-B cells : 62.66% ;
Spleen-Fibroblasts : 59.49% ;
Lung-ATII : 55.82% ;
Lung-ATI : 64.28% ;
Lung-Epithelial cells : 48.18% ;
Spleen-Macrophages : 42.48% ;
Lung-Ciliated cells : 40.45% ;
Spleen-B cells : 40.28% ;
Lung-ATI : 58.93% ;
Liver-Hepatocytes : 50.34% ;
Lung-ATII : 45.79% ;
Liver-Liver sinusoidal endothelial cells : 41.21% ;
Lung-Ciliated cells : 40.91% ;
Echovirus E8
Lung-ATI : 73.85% ;
Lung-Epithelial cells : 66.42% ;
Spleen-B cells : 62.66% ;
Spleen-Fibroblasts : 59.49% ;
Lung-ATII : 55.82% ;
Simian rotavirus A strain RRV
Lung-ATI : 73.85% ;
Lung-Epithelial cells : 66.42% ;
Spleen-B cells : 62.66% ;
Spleen-Fibroblasts : 59.49% ;
Lung-ATII : 55.82% ;
Lung-Endothelial cells : 66.72% ;
Lung-Ciliated cells : 64.09% ;
Lung-Epithelial cells : 62.04% ;
Lung-ATII : 61.40% ;
Lung-ATI : 58.02% ;
Lung-ATI : 64.28% ;
Lung-Epithelial cells : 48.18% ;
Spleen-Macrophages : 42.48% ;
Lung-Ciliated cells : 40.45% ;
Spleen-B cells : 40.28% ;
Human rotavirus strain WA
Lung-ATI : 73.85% ;
Lung-Epithelial cells : 66.42% ;
Spleen-B cells : 62.66% ;
Spleen-Fibroblasts : 59.49% ;
Lung-ATII : 55.82% ;
Echovirus E1
Lung-ATI : 73.85% ;
Lung-Epithelial cells : 66.42% ;
Spleen-B cells : 62.66% ;
Spleen-Fibroblasts : 59.49% ;
Lung-ATII : 55.82% ;
Adeno-associated virus - 2
Lung-ATI : 73.85% ;
Lung-Epithelial cells : 66.42% ;
Spleen-B cells : 62.66% ;
Spleen-Fibroblasts : 59.49% ;
Lung-ATII : 55.82% ;
Lung-ATI : 59.68% ;
Lung-Ciliated cells : 46.36% ;
Lung-Epithelial cells : 36.50% ;
Lung-ATII : 33.18% ;
Spleen-B cells : 31.97% ;
Human metapneumovirus
Lung-ATI : 73.85% ;
Lung-Epithelial cells : 66.42% ;
Spleen-B cells : 62.66% ;
Spleen-Fibroblasts : 59.49% ;
Lung-ATII : 55.82% ;
Human parvovirus B19
Lung-ATI : 73.85% ;
Lung-Epithelial cells : 66.42% ;
Spleen-B cells : 62.66% ;
Spleen-Fibroblasts : 59.49% ;
Lung-ATII : 55.82% ;
Human gammaherpesvirus 8
Lung-ATI : 64.28% ;
Lung-Epithelial cells : 48.18% ;
Spleen-Macrophages : 42.48% ;
Lung-Ciliated cells : 40.45% ;
Spleen-B cells : 40.28% ;
West Nile virus
Lung-ATI : 64.28% ;
Lung-Epithelial cells : 48.18% ;
Spleen-Macrophages : 42.48% ;
Lung-Ciliated cells : 40.45% ;
Spleen-B cells : 40.28% ;
Human parechovirus 1
Lung-ATI : 64.28% ;
Lung-Epithelial cells : 48.18% ;
Spleen-Macrophages : 42.48% ;
Lung-Ciliated cells : 40.45% ;
Spleen-B cells : 40.28% ;
Enterovirus A71
Frontal-Excitatory neurons : 63.16% ;
Lung-Ciliated cells : 56.82% ;
Frontal-Inhibitory neurons : 56.10% ;
Frontal-Oligodendrocytes : 55.33% ;
Frontal-Astrocytes : 53.23% ;
Coxsackievirus A16
Frontal-Excitatory neurons : 63.16% ;
Lung-Ciliated cells : 56.82% ;
Frontal-Inhibitory neurons : 56.10% ;
Frontal-Oligodendrocytes : 55.33% ;
Frontal-Astrocytes : 53.23% ;
Ebola virus
Lung-ATII : 62.35% ;
Lung-Macrophages : 48.52% ;
Lung-Epithelial cells : 37.96% ;
Lung-ATI : 31.91% ;
Lung-Endothelial cells : 29.98% ;
Spleen-T follicular helper cells : 60.77% ;
Frontal-Astrocytes : 59.11% ;
Spleen-T cells : 51.57% ;
Frontal-Microglia : 48.85% ;
Spleen-B cells : 47.06% ;
Marburg marburgvirus
Spleen-T follicular helper cells : 60.77% ;
Frontal-Astrocytes : 59.11% ;
Spleen-T cells : 51.57% ;
Frontal-Microglia : 48.85% ;
Spleen-B cells : 47.06% ;
Xenotropic murine leukemia virus
Lung-ATII : 56.35% ;
Lung-ATI : 42.97% ;
Lung-Epithelial cells : 37.23% ;
Frontal-Excitatory neurons : 31.27% ;
Lung-Ciliated cells : 30.91% ;
Polytropic murine leukemia virus
Lung-ATII : 56.35% ;
Lung-ATI : 42.97% ;
Lung-Epithelial cells : 37.23% ;
Frontal-Excitatory neurons : 31.27% ;
Lung-Ciliated cells : 30.91% ;
Nipah henipavirus
Lung-Endothelial cells : 55.02% ;
Spleen-Endothelial cells : 50.85% ;
Kidney-Endothelial cells : 36.09% ;
Lung-ATI : 31.07% ;
Hendra henipavirus
Lung-Endothelial cells : 55.02% ;
Spleen-Endothelial cells : 50.85% ;
Kidney-Endothelial cells : 36.09% ;
Lung-ATI : 31.07% ;
Human papillomavirus type 16
Lung-ATII : 53.86% ;
Frontal-Endothelial cells : 51.67% ;
Lung-Endothelial cells : 38.39% ;
Lung-Epithelial cells : 34.31% ;
Liver-Hepatocytes : 33.72% ;
Rhinovirus C
Lung-Ciliated cells : 53.64% ;
JC polyomavirus
Frontal-Excitatory neurons : 51.38% ;
Human alphaherpesvirus 3
Frontal-Excitatory neurons : 49.60% ;
Lung-ATI : 43.86% ;
Frontal-Endothelial cells : 33.33% ;
Spleen-Macrophages : 32.52% ;
Spleen-B cells : 31.33% ;
Varicella Zoster Virus
Frontal-Excitatory neurons : 49.60% ;
Lung-ATI : 43.86% ;
Frontal-Endothelial cells : 33.33% ;
Spleen-Macrophages : 32.52% ;
Spleen-B cells : 31.33% ;
Jaagsiekte sheep retrovirus
Frontal-Endothelial cells : 45.00% ;
Lung-Ciliated cells : 35.91% ;
Latino mammarenavirus
Kidney-Podocytes : 42.19% ;
Lung-ATI : 38.69% ;
Oliveros mammarenavirus
Kidney-Podocytes : 42.19% ;
Lung-ATI : 38.69% ;
Lassa mammarenavirus
Kidney-Podocytes : 42.19% ;
Lung-ATI : 38.69% ;
Lymphocytic choriomeningitis mammarenavirus
Kidney-Podocytes : 42.19% ;
Lung-ATI : 38.69% ;
Coxsackievirus A10
Lung-Ciliated cells : 41.36% ;
Feline leukemia virus strain C/FA27
Lung-ATII : 38.41% ;
Human mastadenovirus B
Spleen-B cells : 37.98% ;
Spleen-Dendritic cells : 35.91% ;
Amphotropic murine leukemia virus
Frontal-Smooth muscle cells : 32.95% ;
Feline leukemia virus strain B/lambda-B1
Frontal-Smooth muscle cells : 32.95% ;
Gibbon ape leukemia virus
Frontal-Smooth muscle cells : 32.95% ;
Phocine morbillivirus
Spleen-Naive T cells : 32.81% ;
Measles morbillivirus
Spleen-Naive T cells : 32.81% ;
Canine morbillivirus
Spleen-Naive T cells : 32.81% ;
Rinderpest morbillivirus
Spleen-Naive T cells : 32.81% ;

Contact Us

E-mail: chendongsheng@genomics.cn

Address: Build 11, Beishan Industrial Zone, Yantian District, Shenzhen, 518083, China

Copyright © VThunter 2020-2021 ShenZhen, Guangdong province, China